With Scientific, Operational, and Commercial Acumen GBC Offers Practical Solutions to Turn Expertise and Innovation into Success Neil R. Mucci CEO - GBC Informed, Fast, and Adaptive Approaches to Clinical Research Studies Clinical Trial Management, Quality System Management, and Monitoring Services Biospecimen Acquisition and Biorepository Expertise Committed to Shortening Research and Development Timelines and Maximizing Client Value Accelerating the Promise of Predictive, Prognostic, Personalized, and Participatory Medicine Global BioClinical In Vitro Diagnostic Clinical Trial Services Consulting Business Clinical Trials Biospecimens NEWS Teal Health Completes Clinical Trial at Record Speed and Receives FDA Breakthrough Designation for Its At-Home Cervical Cancer Screening Device, the Teal Wand™OpGen Submits De Novo Request to the U.S. FDA for Unyvero Urinary Tract Infection (UTI) PanelOpGen Announces Positive Top Line Data from Clinical Trial for Unyvero Urinary Tract Infection (UTI) PanelInfanDx Tackles Early Detection of Hypoxic Ischemic Encephalopathy GBC BLOG Biotech firm Recursion to Buy Smaller Peer ExscientiaFred Hutch Unveils Results of New Blood Test That Detects Colon CancerBacteria Subtype Linked to Growth in Up to 50% of Human Colorectal CancersKLAS Research U.S. Digital Pathology Report Confirms Philips As One of The Industry’s Leading Players
